Individuals Discontinuing Slimming Medications Regain Weight at a Quadrupled Rate Than Dieters
A recent study reveals that people who discontinue new slimming jabs like semaglutide or tirzepatide may regain lost weight at a significantly accelerated pace than those who end traditional lifestyle plans.
Research printed in a leading health publication demonstrates that while overweight people frequently drop substantial amounts of their total mass while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"Users buying such medications must be aware of the danger of fast weight regain when the therapy ends," stated expert Dr. Susan Jebb.
Such speed of regain means a reversion to original weight within about a year and a half.
Comparing Approaches
The analysis, which reviewed dozens of trials involving thousands of patients, contrasted the outcomes of the injectable medications with conventional dieting.
Researchers emphasize that people who shed pounds through diet and exercise usually experience a less rapid weight regain—around 0.1 kg a month—after stopping.
Explaining the Fast Rebound
Experts believe the mode of action of the drugs is key to understanding the amplified regain.
The injections imitate a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Artificially providing the hormone levels far above than the body's typical production may cause the system to generate a reduced amount of its endogenous GLP-1, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this hormone supplement leads to appetite is uncontrolled, making overeating much more probable."
A Chronic Issue?
The NHS advise the injections for people with obesity-related medical conditions, alongside prescribed lifestyle changes.
Professionals argue that, given the likelihood of relapse, the treatment might need to be life-long.
This perspective is supported by pharmaceutical companies, who note that the findings "emphasize the chronic nature of excess weight," akin to managing conditions like high blood pressure.
User Testimonies
Individuals who have come off the medication explain a powerful return of cravings.
"I experienced a switch activating and I was suddenly ravenous," recalled a patient.
This difficulty is exacerbated if patients have not developed lasting lifestyle or habit modifications during treatment.
Growing Use
Recent estimates indicate that millions of people in the UK have tried these injections in the past year, with demand being substantial.
- Use is higher among females compared to men.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion access the medications through private healthcare rather than the NHS.
In conclusion, clinicians emphasize that while these medications are potent tools for shedding pounds, they are not a permanent fix and lasting health benefits hinges on combined lifestyle support.
